The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Vaccine Development to Prevent Cytomegalovirus Disease: Report from the National Vaccine Advisory Committee
Abstract
Cytomegalovirus (CMV) infection is the most common intrauterine infection in the United States, and it exacts a heavy toll when it infects children and immunocompromised individuals. A CMV vaccine was assigned the highest priority by the Institute of Medicine in its 1999 assessment of targets for vaccine development. The priority was based on the cost and human suffering that would be alleviated by reducing the disease burden of congenital CMV infection. The National Vaccine Advisory Committee and invited experts examined the prospects for a CMV vaccine and the actions needed to bring about successful vaccine development at a National Vaccine Program Office workshop in October 2000. This article summarizes information about the changing epidemiology of CMV and immune responses to infection and immunity, and it reviews the current status of several vaccine candidates. Support of government agencies for CMV vaccine research and development is critical to address this need.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D., & Riddell, S. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510193331603 · Cited by 1,771
Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E., & Greenberg, P. D. (1992) · Science · doi:10.1126/science.1352912 · Cited by 1,201
The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody Status
Fowler, K. B., Stagno, S., Pass, R. F., Britt, W. J., Boll, T. J., & Alford, C. A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261003 · Cited by 1,084
Viral Subversion of the Immune System
Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J., & Ploegh, H. L. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.861 · Cited by 835
Viral Strategies of Immune Evasion
Ploegh, H. L. (1998) · Science · doi:10.1126/science.280.5361.248 · Cited by 778
Wills, M. R., Carmichael, A. J., Mynard, K., Jin, X., Weekes, M. P., Plachter, B., & Sissons, J. G. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7569-7579.1996 · Cited by 688
Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant
Revello, M. G., & Gerna, G. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.680-715.2002 · Cited by 618
Waldrop, S. L., Pitcher, C. J., Peterson, D. M., Maino, V. C., & Picker, L. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119338 · Cited by 545
Maternal Immunity and Prevention of Congenital Cytomegalovirus Infection
Fowler, K. B., Stagno, S., & Pass, R. F. (2003) · JAMA · doi:10.1001/jama.289.8.1008 · Cited by 440
Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications
Boeckh, M., & Boivin, G. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.533 · Cited by 438
Fisher, S., Genbacev, O., Maidji, E., & Pereira, L. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.6808-6820.2000 · Cited by 352
(2010) · Clinical Transplantation · doi:10.1111/(issn)1399-0012 · Cited by 300
Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance
Reddehase, M. J. (2002) · Nature Reviews Immunology · doi:10.1038/nri932 · Cited by 291
Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion
Mocarski, E. S. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02393-4 · Cited by 287
Kern, F., Bunde, T., Faulhaber, N., Kiecker, F., Khatamzas, E., Rudawski, I., Pruss, A., Gratama, J., Volkmer‐Engert, R., Ewert, R., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/340637 · Cited by 277
A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant
Pass, R. F., Duliegè, A., Boppana, S., Sekulovich, R., Percell, S., Britt, W., & Burke, R. L. (1999) · The Journal of Infectious Diseases · doi:10.1086/315022 · Cited by 249
Principles for Adoptive T Cell Therapy of Human Viral Diseases
Riddell, S. R. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.545 · Cited by 248
Diamond, D. J., York, J., Sun, J.-Y., Wright, C. L., & Forman, S. J. (1997) · Blood · doi:10.1182/blood.v90.5.1751 · Cited by 248
Asymptomatic Primary Cytomegalovirus Infection: Virologic and Immunologic Features
Zanghellini, F., Boppana, S. B., Emery, V. C., Griffiths, P. D., & Pass, R. F. (1999) · The Journal of Infectious Diseases · doi:10.1086/314939 · Cited by 236
Plotkin, S. A., Starr, S. E., Friedman, H. M., Brayman, K., Harris, S., Jackson, S., Tustin, N. B., Grossman, R., Dafoe, D., & Barker, C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-7-525 · Cited by 198
Self-citationCytomegalovirus and Child Day Care
Adler, S. P. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211903 · Cited by 194
Human Cytomegalovirus Glycoproteins
Britt, W. J., & Mach, M. (1996) · Intervirology · doi:10.1159/000150510 · Cited by 191
Gyulai, Z., Endrész, V., Burián, K., Pincus, S. E., Toldy, J., Cox, W. I., Meri, C., Plotkin, S. A., & Berencsi, K. (2000) · The Journal of Infectious Diseases · doi:10.1086/315445 · Cited by 142
Self-citationCongenital cytomegalovirus infection and neonatal auditory screening
Hicks, T., Fowler, K. B., Richardson, M., Dahle, A. J., Adams, L. E., & Pass, R. F. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80859-5 · Cited by 134
Maidji, E., Percivalle, E., Gerna, G., Fisher, S. J., & Pereira, L. (2002) · Virology · doi:10.1006/viro.2002.1661 · Cited by 106
Frey, S. E., Harrison, C., Pass, R. F., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315060 · Cited by 105
Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers
Mitchell, D. K., Holmes, S. J., BURKE, R. L., et al. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200202000-00009 · Cited by 98
Bernstein, D. I., Schleiss, M. R., Berencsi, K., Gönczöl, É., Dickey, M., Khoury, P., Cadoz, M., Méric, C., Zahradnik, J. M., Duliège, A., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/339003 · Cited by 77
Self-citationGłowacki, Ł., & Smaill, F. (1994) · Clinical Transplantation · doi:10.1111/j.1399-0012.1994.tb00935.x · Cited by 60
Głowacki, Ł., & Smaill, F. (1994) · PubMed · Cited by 51
Plotkin, S. A. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70281-4 · Cited by 28
Self-citationTsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Cited by
Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
Kenneson, A., & Cannon, M. J. (2007) · Reviews in Medical Virology · doi:10.1002/rmv.535 · Cited by 1,720
The “Silent” Global Burden of Congenital Cytomegalovirus
Manicklal, S., Emery, V. C., Lazzarotto, T., Boppana, S. B., & Gupta, R. K. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00062-12 · Cited by 1,028
Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta‐analysis
Zuhair, M., Smit, G. S. A., Wallis, G., Jabbar, F., Smith, C., Devleesschauwer, B., & Griffiths, P. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2034 · Cited by 889
Bate, S. L., Dollard, S. C., & Cannon, M. J. (2010) · Clinical Infectious Diseases · doi:10.1086/652438 · Cited by 681
Vaccines: past, present and future
Plotkin, S. A. (2005) · Nature Medicine · doi:10.1038/nm1209 · Cited by 592
Self-citation
Metadata
- Authors
- Modlin, J. F., Arvin, A. M., Fast, P., Myers, M., Plotkin, S., & Rabinovich, R.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-07-15
- Volume
- 39
- Issue
- 2
- Pages
- 233-239
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2145301696
- Cited by
- 331
- References
- 32
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.